Life Sciences Tools and Services
Company Overview of Novella Clinical, Inc.
Novella Clinical, Inc. provides preclinical to post-approval clinical trial management services to clients in oncology, medical device, biopharmaceutical, and diagnostic industries. Its services include project management, clinical monitoring, data management, data monitoring, investigator strategies and site coordination, safety management, medical monitoring, medical writing, regulatory services, quality assurance, steering and clinical advisory services, and training. The company also offers various resourcing solutions ranging from functional service provider programs to contract staffing and direct hire services in the areas of dedicated functional teams, individual contractors, entire ...
1700 Perimeter Park Drive
Morrisville, NC 27560
Founded in 1998
Key Executives for Novella Clinical, Inc.
Executive Vice President of Operations for Clinical Monitoring
Executive Vice President of Clinical Operations for Project Management & Training
Compensation as of Fiscal Year 2015.
Novella Clinical, Inc. Key Developments
ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma
Jul 6 15
ImmunoCellular Therapeutics, Ltd. announced the establishment of an agreement with Novella Clinical, to conduct the phase 3 registration trial of ICT-107 in patients with newly diagnosed glioblastoma. Novella is a full-service, global clinical research organization (CRO) providing clinical trial services to small to mid-sized oncology companies. The ICT-107 phase 3 trial will include approximately 120 clinical sites in the US, Europe and Canada, and will recruit about 400 patients with newly diagnosed glioblastoma. ImmunoCellular anticipates initiating the phase 3 trial in the fourth quarter of 2015.
Novella Clinical Appoints Deepak Dhami as European Director
Sep 24 14
Novella Clinical announced the appointment of a director for its European clinical monitoring unit. Pharmafile has reported that Dr. Deepak Dhami has been appointed to the position. With over 20 years of clinical research and operations experience in the pharmaceutical industry, Dr. Dhami has served as functional manager for study management, oncology (pharma development) at Roche, and provided strategic direction on clinical studies for numerous pharma firms in Europe.
Novella Clinical Names Dr. Chris Smyth Managing Director of European and Asian Operations Replacing Elizabeth Edwards
Mar 11 14
Novella Clinical, Inc. announced the appointment of Chris Smyth, Ph.D., MBA as managing director of European and Asian operations. Smyth joins Novella Clinical (Novella) with more than 20 years research and development experience in the pharmaceutical industry. Prior to joining Novella, he served as senior vice president of clinical development in the oncology division of INC Research. Smyth also will lead oncology delivery operations in all markets outside the U.S. He succeeds Elizabeth Edwards, who will now serve as executive vice president of global operations, overseeing Novella's clinical monitoring division.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|